These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Second-generation antipsychotics for major depressive disorder and dysthymia. Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393 [TBL] [Abstract][Full Text] [Related]
3. Quetiapine versus other atypical antipsychotics for schizophrenia. Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315 [TBL] [Abstract][Full Text] [Related]
4. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience. Tundo A; de Filippis R; Proietti L World J Psychiatry; 2015 Sep; 5(3):330-41. PubMed ID: 26425446 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and Tolerability of Atypical Antipsychotics in the Treatment of Delirium: A Systematic Review of the Literature. Rivière J; van der Mast RC; Vandenberghe J; Van Den Eede F Psychosomatics; 2019; 60(1):18-26. PubMed ID: 30181002 [TBL] [Abstract][Full Text] [Related]
11. Typical and atypical antipsychotics in bipolar depression. Gao K; Gajwani P; Elhaj O; Calabrese JR J Clin Psychiatry; 2005 Nov; 66(11):1376-85. PubMed ID: 16420074 [TBL] [Abstract][Full Text] [Related]
12. Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis. Zhou X; Keitner GI; Qin B; Ravindran AV; Bauer M; Del Giovane C; Zhao J; Liu Y; Fang Y; Zhang Y; Xie P Int J Neuropsychopharmacol; 2015 May; 18(11):pyv060. PubMed ID: 26012350 [TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy for Treatment-Resistant Depression: Antidepressants and Atypical Antipsychotics. Vas C; Jain A; Trivedi M; Jha MK; Mathew SJ Psychiatr Clin North Am; 2023 Jun; 46(2):261-275. PubMed ID: 37149344 [TBL] [Abstract][Full Text] [Related]
14. Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol. Goikolea JM; Colom F; Torres I; Capapey J; Valentí M; Undurraga J; Grande I; Sanchez-Moreno J; Vieta E J Affect Disord; 2013 Jan; 144(3):191-8. PubMed ID: 23089129 [TBL] [Abstract][Full Text] [Related]
15. Aripiprazole versus other atypical antipsychotics for schizophrenia. Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570 [TBL] [Abstract][Full Text] [Related]
16. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Ballard C; Waite J Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455 [TBL] [Abstract][Full Text] [Related]
17. [Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy]. Erbe S; Gutwinski S; Bschor T Psychiatr Prax; 2012 Mar; 39(2):57-63. PubMed ID: 22189902 [TBL] [Abstract][Full Text] [Related]
18. Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder. Shelton RC; Papakostas GI Acta Psychiatr Scand; 2008 Apr; 117(4):253-9. PubMed ID: 18190674 [TBL] [Abstract][Full Text] [Related]